Pages that link to "Q89975279"
Jump to navigation
Jump to search
The following pages link to Structure of Mpro from COVID-19 virus and discovery of its inhibitors (Q89975279):
Displaying 50 items.
- Structure of Mpro from COVID-19 virus and discovery of its inhibitors (Q87967188) (← links)
- SARS-CoV-2 main protease complex (Q90012264) (← links)
- (Q91220112) (redirect page) (← links)
- Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms (Q91954116) (← links)
- A deadly spillover: SARS-CoV-2 outbreak (Q93159052) (← links)
- Andrographolide As a Potential Inhibitor of SARS-CoV-2 Main Protease: An In Silico Approach (Q93204131) (← links)
- Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study (Q93263973) (← links)
- Maternal Death Due to COVID-19 Disease (Q94489773) (← links)
- Candidate drugs against SARS-CoV-2 and COVID-19 (Q94491475) (← links)
- Using Integrated Computational Approaches to Identify Safe and Rapid Treatment for SARS -CoV- 2 (Q94506619) (← links)
- Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur (Q94550633) (← links)
- Selenylated-oxadiazoles as promising DNA intercalators: Synthesis, electronic structure, DNA interaction and cleavage (Q94551290) (← links)
- COVID-19: Living through Another Pandemic (Q94598529) (← links)
- Computational screening of antagonist against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking (Q94602011) (← links)
- Statins and the COVID-19 main protease: in silico evidence on direct interaction (Q94602021) (← links)
- In silico fight against novel coronavirus by finding chromone derivatives as inhibitor of coronavirus main proteases enzyme (Q94932863) (← links)
- The sprint to solve coronavirus protein structures - and disarm them with drugs (Q94948755) (← links)
- Lithium's antiviral effects: a potential drug for CoViD-19 disease? (Q95272543) (← links)
- Ebselen as a highly active inhibitor of PLProCoV2 (Q95604288) (← links)
- Chemistry and Biology of SARS-CoV-2 (Q95630795) (← links)
- The G-Quadruplex/Helicase World as a Potential Antiviral Approach Against COVID-19 (Q95835634) (← links)
- Corona virus versus existence of human on the earth: A computational and biophysical approach (Q96225284) (← links)
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease (Q96431581) (← links)
- The Se…S/N interactions as a possible mechanism of δ-aminolevulinic acid dehydratase enzyme inhibition by organoselenium compounds: A computational study (Q96641807) (← links)
- Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography (Q96683475) (← links)
- Direct SARS-CoV-2 infection of the heart potentiates the cardiovascular sequelae of COVID-19 (Q96768947) (← links)
- Bioactive Indolyl Diketopiperazines from the Marine Derived Endophytic Aspergillus versicolor DY180635 (Q96810122) (← links)
- Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors (Q97086757) (← links)
- Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies (Q97087797) (← links)
- Revisiting potential druggable targets against SARS-CoV-2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review (Q97430314) (← links)
- Characteristics of the Coronavirus Disease 2019 and related Therapeutic Options (Q97526973) (← links)
- Computational insights into tetracyclines as inhibitors against SARS-CoV-2 Mpro via combinatorial molecular simulation calculations (Q97551132) (← links)
- SARS-CoV and SARS-CoV-2 main protease residue interaction networks change when bound to inhibitor N3 (Q97552375) (← links)
- Selenium - associated gene signatures within the SARS-CoV-2 - host genomic interaction interface (Q97560330) (← links)
- Structure-based drug designing and immunoinformatics approach for SARS-CoV-2 (Q97636626) (← links)
- GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response (Q97644541) (← links)
- Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses (Q97878176) (← links)
- Turning the Tide: Natural Products and Natural-Product-Inspired Chemicals as Potential Counters to SARS-CoV-2 Infection (Q97883067) (← links)
- Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity (Q98162461) (← links)
- SARS-CoV-2 and cancer: Are they really partners in crime? (Q98172049) (← links)
- Progress in the Research and Development of Anti-COVID-19 Drugs (Q98178356) (← links)
- Roles of flavonoids against coronavirus infection (Q98181434) (← links)
- Structural stability of the SARS-CoV-2 main protease: Can metal ions affect function? (Q98182352) (← links)
- Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients (Q98184361) (← links)
- In crystallo-screening for discovery of human norovirus 3C-like protease inhibitors (Q98191440) (← links)
- Cryo-electron Microscopy and Exploratory Antisense Targeting of the 28-kDa Frameshift Stimulation Element from the SARS-CoV-2 RNA Genome (Q98191507) (← links)
- Selenium and viral infection: are there lessons for COVID-19? (Q98215945) (← links)
- Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality (Q98390836) (← links)
- Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis (Q98465610) (← links)
- Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors (Q98467298) (← links)